AdvanCell

“AdvanCell Raised $315M Series D for lead-212 targeted alpha radiation cancer therapies — the largest single round in the issue.”

“Raised $315M Series D led by Ally Bridge Group and Alpha Wave”

“AdvanCell, "an Australia-based radiopharmaceutical company focused on cancer, raised $315m in Series D funding."”

“The pattern: healthcare AI and diagnostics are attracting mega-rounds at steep step-ups.”